Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs Nomad Power Solutions, Inc. (NMAD)

Cognition Therapeutics, Inc. and Nomad Power Solutions, Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and Nomad Power Solutions, Inc. are of similar size ($69.7M and $65.9M). Across the 9 metrics below, Cognition Therapeutics, Inc. leads on 6 and Nomad Power Solutions, Inc. on 3.

Valuation

Metric CGTX NMAD Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.00 2.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (23.29%) (25.77%) (33.15%)
Free cash flow yield (26.75%) (10.44%) (25.50%)

Profitability

Metric CGTX NMAD Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (83.76%) (68.04%) (56.36%)
Return on assets (57.33%) (62.67%) (48.04%)
Return on invested capital 0.00% (40.41%) 0.00%

Growth

Metric CGTX NMAD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 62.79% 20.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX NMAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 12.87 4.72
Net debt to EBITDA 0.78 1.00 0.96

Dividend

Metric CGTX NMAD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGTX NMAD Biotechnology median
Market cap 69.67m 65.85m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack